We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

58 hedge funds and large institutions have $286M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $227K | Put options by funds: $169K

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

7% more funds holding

Funds holding: 54 → 58 (+4)

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less capital invested

Capital invested by funds: $303M → $286M (-$16.8M)

Holders
58
Holders Change
+4
Holders Change %
+7.41%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
16
Increased
16
Reduced
15
Closed
12
Calls
$227K
Puts
$169K
Net Calls
+$58K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.31M
2
State Street
State Street
Massachusetts
+$2.61M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.04M
4
Northern Trust
Northern Trust
Illinois
+$1.29M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$667K

Top Sellers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
-$4.28M
2
OIM
Oracle Investment Management
Connecticut
-$1.07M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.06M
4
Millennium Management
Millennium Management
New York
-$985K
5
Jane Street
Jane Street
New York
-$556K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$164M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$30.4M +$134K +17,114 +0.3%
HP
3
Harbourvest Partners
Massachusetts
$19.7M – – –
AG
4
Artal Group
Luxembourg
$14.2M – – –
State of Wisconsin Investment Board
5
State of Wisconsin Investment Board
Wisconsin
$10.4M +$14.9K +1,900 +0.1%
BlackRock
6
BlackRock
New York
$9.01M +$8.31M +1,062,612 +194%
Vanguard Group
7
Vanguard Group
Pennsylvania
$8.31M +$667K +85,302 +6%
CA
8
CHI Advisors
New York
$5.91M – – –
PIM
9
Platinum Investment Management
Australia
$4.97M -$273K -34,956 -4%
6CM
10
683 Capital Management
New York
$2.66M -$433K -55,310 -10%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.48M +$2.04M +261,379 +144%
State Street
12
State Street
Massachusetts
$2.18M +$2.61M +333,403 +598%
7IH
13
72 Investment Holdings
Connecticut
$1.98M – – –
SOMRS
14
State of Michigan Retirement System
Michigan
$1.76M – – –
Northern Trust
15
Northern Trust
Illinois
$1.14M +$1.29M +164,939 +419%
OIM
16
Oracle Investment Management
Connecticut
$1.11M -$1.07M -136,387 -41%
KCM
17
Knoll Capital Management
Florida
$969K – – –
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$725K -$14.1K -1,800 -1%
Millennium Management
19
Millennium Management
New York
$492K -$985K -125,893 -59%
Morgan Stanley
20
Morgan Stanley
New York
$436K +$45K +5,746 +8%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$407K +$487K +62,282 +602%
RC
22
RBF Capital
California
$392K – – –
Charles Schwab
23
Charles Schwab
California
$365K +$509K +65,111 New
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$330K -$1.06M -134,883 -70%
Citigroup
25
Citigroup
New York
$279K -$51.5K -6,585 -12%
1
2 3

OMGA Hedge Fund Activity: Q2 2023 in Review

58 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q2 2023, worth a combined $286M — down 5.5% from $303M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new OMGA positions and 12 closed out — a net gain of 4 holders — while 16 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $8.31M. The largest seller was Laurion Capital Management, cutting an estimated $4.28M.

  • 58 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q2 2023, up from 54 in Q1 2023.
  • Funds reported $286M of Omega Therapeutics, Inc. Common Stock stock for Q2 2023, down 5.5% quarter-over-quarter.
  • 16 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q2 2023 and 12 closed out, a net change of +4 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q2 2023 was BlackRock, an estimated $8.31M added.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q2 2023 was Laurion Capital Management, an estimated $4.28M sold.

Based on aggregated 13F filings for Q2 2023.